XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,254,559 | -11.3% | 212,370 | -0.1% | 0.00% | – |
| Q2 2023 | $8,183,175 | +10.2% | 212,550 | +2.5% | 0.00% | – |
| Q1 2023 | $7,424,700 | -52.3% | 207,456 | -47.5% | 0.00% | – |
| Q4 2022 | $15,569,802 | +153.2% | 394,872 | +131.8% | 0.00% | – |
| Q3 2022 | $6,150,000 | +2.5% | 170,371 | -13.6% | 0.00% | – |
| Q2 2022 | $5,999,000 | +14.1% | 197,221 | +14.7% | 0.00% | – |
| Q1 2022 | $5,258,000 | +4.4% | 171,987 | +6.7% | 0.00% | – |
| Q4 2021 | $5,037,000 | +123.6% | 161,249 | +9.4% | 0.00% | – |
| Q3 2021 | $2,253,000 | -7.4% | 147,447 | +12.9% | 0.00% | – |
| Q2 2021 | $2,432,000 | +38.5% | 130,595 | +33.1% | 0.00% | – |
| Q1 2021 | $1,756,000 | +22.3% | 98,088 | +5.0% | 0.00% | – |
| Q4 2020 | $1,436,000 | +44.9% | 93,386 | +4.3% | 0.00% | – |
| Q3 2020 | $991,000 | -8.8% | 89,547 | +3.3% | 0.00% | – |
| Q2 2020 | $1,087,000 | +405.6% | 86,664 | +356.7% | 0.00% | – |
| Q1 2020 | $215,000 | -19.5% | 18,978 | -6.8% | 0.00% | – |
| Q4 2019 | $267,000 | +43.5% | 20,360 | -1.5% | 0.00% | – |
| Q3 2019 | $186,000 | -8.8% | 20,664 | 0.0% | 0.00% | – |
| Q2 2019 | $204,000 | -2.9% | 20,664 | 0.0% | 0.00% | – |
| Q1 2019 | $210,000 | +56.7% | 20,664 | -2.9% | 0.00% | – |
| Q4 2018 | $134,000 | -47.9% | 21,288 | +9.2% | 0.00% | – |
| Q3 2018 | $257,000 | – | 19,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 850,000 | $15,215,000 | 3.58% |
| ACUTA CAPITAL PARTNERS, LLC | 412,500 | $7,384,000 | 2.66% |
| BVF INC/IL | 3,481,778 | $62,324,000 | 2.34% |
| Soleus Capital Management, L.P. | 708,117 | $12,675,000 | 2.28% |
| COMMODORE CAPITAL LP | 301,392 | $5,395,000 | 2.15% |
| DAFNA Capital Management LLC | 406,535 | $7,277,000 | 1.73% |
| Parkman Healthcare Partners LLC | 374,395 | $6,702,000 | 1.56% |
| Avoro Capital Advisors LLC | 3,650,000 | $65,335,000 | 1.13% |
| KNOTT DAVID M | 144,101 | $2,579,000 | 1.10% |
| Orbimed Advisors | 2,497,917 | $44,713,000 | 0.42% |